| EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
HUWE1 |
HUWE1, KIAA0312, HSPC272, KIAA1578, UREB1: E3 ubiquitin-protein ligase HUWE1 |
3.575 |
Evidence |
|
| CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
3.575 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
MAP2K5 |
IPI00185860 |
3.575 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
3.575 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PRKAA1 |
IPI00011891 |
3.575 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
TOP2B |
IPI00217709 |
3.575 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
ERF |
ERF: ETS domain-containing transcription factor ERF |
3.575 |
Evidence |
|
| SAT |
SAT1, SAT: Diamine acetyltransferase 1 |
SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
3.575 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
CFL1 |
CFL1, CFL: Cofilin-1 |
3.575 |
Evidence |
|
| LIG1 |
LIG1: DNA ligase 1 |
ERF |
ERF: ETS domain-containing transcription factor ERF |
3.575 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
3.575 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
STRN3 |
STRN3, GS2NA, SG2NA: Striatin-3 |
3.575 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
3.575 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
DNMT1 |
DNMT1, AIM, DNMT: DNA |
3.575 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
3.575 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
TGIF2 |
TGIF2: Homeobox protein TGIF2 |
3.575 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
3.575 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
3.575 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
3.575 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
3.575 |
Evidence |
|
| NFATC1 |
IPI00336007 |
PCNA |
PCNA: Proliferating cell nuclear antigen |
3.575 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
GTF2F2 |
IPI00329767 |
3.575 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
MAP2K5 |
IPI00185860 |
3.575 |
Evidence |
|
| WASPIP |
IPI00552369 |
MICAL-L1 |
MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 |
3.575 |
Evidence |
|
| WASPIP |
IPI00552369 |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
3.575 |
Evidence |
|